Brii Biosciences Limited (HKG:2137)
Hong Kong
· Delayed Price · Currency is HKD 1.550
+0.230 (17.42%)
At close: Mar 10, 2026
Brii Biosciences Market Cap
Brii Biosciences has a market cap or net worth of 952.43 million as of March 10, 2026. Its market cap has increased by 16.96% in one year.
Market Cap
952.43M
Enterprise Value
-1.37B
Revenue
31.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.55
Market Cap Chart
Since July 13, 2021, Brii Biosciences's market cap has decreased from 16.21B to 952.43M, a decrease of -94.12%. That is a compound annual growth rate of -45.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 952.43M | -6.34% |
| Dec 31, 2025 | 1.02B | 41.89% |
| Dec 31, 2024 | 716.67M | -56.90% |
| Dec 29, 2023 | 1.66B | -68.96% |
| Dec 30, 2022 | 5.36B | -77.39% |
| Dec 31, 2021 | 23.70B | 46.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Transcenta Holding | 998.76M |
| Sunho Biologics | 971.95M |
| 3D Medicines | 932.46M |
| Wuhan YZY Biopharma | 1.10B |
| Shanghai Bio-heart Biological Technology | 1.20B |
| JW (Cayman) Therapeutics Co. | 778.83M |
| Beijing Biostar Pharmaceuticals | 1.37B |
| HighTide Therapeutics | 1.37B |